Sponsor Pipeline

Peter Brett, MD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-29 NCT07733466 Open-Label Neoadjuvant Pembrolizumab Plus Cetuximab in Betel Nut-Associated Locally… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07733466 Open-Label Neoadjuvant Pembrolizumab Plus Cetuximab in Betel Nut-Associated Locally… Betel-nut-associated Oral Carcinoma Not Yet Recruiting
Get alerts when Peter Brett, MD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free